Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
Select Page
Why We Invested: Lenoss Medical

Why We Invested: Lenoss Medical

by Xcellerant Ventures | Dec 20, 2023 | Portfolio Company News, Xcellerant Ventures News

Why Xcellerant Ventures Invested in Lenoss Medical The Xcellerant Venture’s team proudly welcomes Lenoss Medical as our 9th portfolio company in Xcellerant Ventures Fund 1. The enthusiasm surrounding their groundbreaking technology is nothing short of exhilarating. In...
This Startup Can Improve Cancer Screenings, Starting With Mammograms

This Startup Can Improve Cancer Screenings, Starting With Mammograms

by Xcellerant Ventures | Dec 19, 2023 | Portfolio Company News

Origionally posted on Forbes.com: https://www.forbes.com/sites/evaepker/2023/12/19/this-startup-can-improve-cancer-screenings-starting-with-mammograms/?sh=2aed40eacae4   Starting just this past March, countless women received a note after their mammogram that...
Xcellerant Ventures Invests in Series A Funding Round for Lenoss Medical

Xcellerant Ventures Invests in Series A Funding Round for Lenoss Medical

by Xcellerant Ventures | Dec 13, 2023 | Portfolio Company News, Xcellerant Ventures News

Origionally posted on Business Wire: https://www.businesswire.com/news/home/20231213775926/en/Xcellerant-Ventures-Invests-in-Series-A-Funding-Round-for-Lenoss-Medical SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures welcomes Lenoss Medical into our...
Barco Announces Partnership with DeepLook Medical for Breast Cancer AI Tool

Barco Announces Partnership with DeepLook Medical for Breast Cancer AI Tool

by Xcellerant Ventures | Nov 20, 2023 | Portfolio Company News

Origionally posted on Barco’s Website: https://www.barco.com/fr/about/press-releases/barco-announces-introduction-of-ai-technology-for-visualization-of-dense-breast-tissue   Barco’s colorful high-resolution monitors burst with more data than ever before...
Unraveling the Value Chain of CRISPR QC: Safeguarding the Future of Gene Editing

Unraveling the Value Chain of CRISPR QC: Safeguarding the Future of Gene Editing

by Xcellerant Ventures | Nov 10, 2023 | Portfolio Company News

This blog was origionally posted on the Digital Journal and can be viewed here: https://www.digitaljournal.com/tech-science/unraveling-the-value-chain-of-crispr-qc-safeguarding-the-future-of-gene-editing We now live in a world where scientists can edit genes, and...
TruLite Health Selected as American Hospital Association Equity Transformation Partner

TruLite Health Selected as American Hospital Association Equity Transformation Partner

by Xcellerant Ventures | Oct 24, 2023 | Portfolio Company News

Content origionally posted on Business Wire: https://www.businesswire.com/news/home/20231024988728/en/TruLite-Health-Selected-as-American-Hospital-Association-Equity-Transformation-Partner TEMPE, Ariz.–(BUSINESS WIRE)–TruLite Health has been selected as an...
« Older Entries
Next Entries »

Recent Posts

  • TruLite Health Partners with Lee Health to Elevate Health Equity Strategy
  • TruLite Health Selected for Microsoft Pegasus Program
  • Xcellerant Ventures Leads DeepLook Medical’s Series A Round
  • DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
  • Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023